Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques

Luis Giavedoni, Shabbir Ahmad, Leslie Jones, Tilahun Yilma

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Simian immunodeficiency virus (SIV) infection of macaques is a model for human immunodeficiency virus (HIV) infection. We have previously reported the construction and characterization of an SIV vector with a deletion in the nef gene (SIV(Δnef)) and expressing gamma interferon (SIV(HyIFN)) (L. Giavedoni and T. Yilma, J. Virol. 70:2247-2251, 1996). We now show that rhesus macaques vaccinated with SIV(HyIFN) have a lower viral load than a group similarly immunized with SIV(Δnef). Viral loads remained low in the SIV(HyIFN)- vaccinated group even though SIV expressing gamma interferon could not be isolated after 6 weeks postimmunization in these animals. All immunized and two naive control macaques became infected when challenged with virulent SIV(mac251) at 25 weeks postvaccination. In contrast to the two naive controls that died by 12 and 18 weeks postchallenge, all vaccinated animals remained healthy for more than 32 weeks. In addition, postchallenge cell- associated virus load was significantly lower in SIV(HyIFN)-immunized animals than in the group vaccinated with SIV(Δnef). These findings indicate that cytokine-expressing viruses can provide a novel approach for development of safe and efficacious live attenuated vaccines for AIDS.

Original languageEnglish (US)
Pages (from-to)866-872
Number of pages7
JournalJournal of Virology
Volume71
Issue number2
StatePublished - Feb 1997

Fingerprint

Simian immunodeficiency virus
Simian Immunodeficiency Virus
viral load
Macaca mulatta
interferon-gamma
Interferon-gamma
Viruses
Macaca
live vaccines
Virus Diseases
Viral Load
nef Genes
Satellite Viruses
animals
Attenuated Vaccines
gene deletion
HIV infections
Acquired Immunodeficiency Syndrome
cytokines

ASJC Scopus subject areas

  • Immunology

Cite this

Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. / Giavedoni, Luis; Ahmad, Shabbir; Jones, Leslie; Yilma, Tilahun.

In: Journal of Virology, Vol. 71, No. 2, 02.1997, p. 866-872.

Research output: Contribution to journalArticle

@article{754989cc89e8461dbe6520986bf62eaa,
title = "Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques",
abstract = "Simian immunodeficiency virus (SIV) infection of macaques is a model for human immunodeficiency virus (HIV) infection. We have previously reported the construction and characterization of an SIV vector with a deletion in the nef gene (SIV(Δnef)) and expressing gamma interferon (SIV(HyIFN)) (L. Giavedoni and T. Yilma, J. Virol. 70:2247-2251, 1996). We now show that rhesus macaques vaccinated with SIV(HyIFN) have a lower viral load than a group similarly immunized with SIV(Δnef). Viral loads remained low in the SIV(HyIFN)- vaccinated group even though SIV expressing gamma interferon could not be isolated after 6 weeks postimmunization in these animals. All immunized and two naive control macaques became infected when challenged with virulent SIV(mac251) at 25 weeks postvaccination. In contrast to the two naive controls that died by 12 and 18 weeks postchallenge, all vaccinated animals remained healthy for more than 32 weeks. In addition, postchallenge cell- associated virus load was significantly lower in SIV(HyIFN)-immunized animals than in the group vaccinated with SIV(Δnef). These findings indicate that cytokine-expressing viruses can provide a novel approach for development of safe and efficacious live attenuated vaccines for AIDS.",
author = "Luis Giavedoni and Shabbir Ahmad and Leslie Jones and Tilahun Yilma",
year = "1997",
month = "2",
language = "English (US)",
volume = "71",
pages = "866--872",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques

AU - Giavedoni, Luis

AU - Ahmad, Shabbir

AU - Jones, Leslie

AU - Yilma, Tilahun

PY - 1997/2

Y1 - 1997/2

N2 - Simian immunodeficiency virus (SIV) infection of macaques is a model for human immunodeficiency virus (HIV) infection. We have previously reported the construction and characterization of an SIV vector with a deletion in the nef gene (SIV(Δnef)) and expressing gamma interferon (SIV(HyIFN)) (L. Giavedoni and T. Yilma, J. Virol. 70:2247-2251, 1996). We now show that rhesus macaques vaccinated with SIV(HyIFN) have a lower viral load than a group similarly immunized with SIV(Δnef). Viral loads remained low in the SIV(HyIFN)- vaccinated group even though SIV expressing gamma interferon could not be isolated after 6 weeks postimmunization in these animals. All immunized and two naive control macaques became infected when challenged with virulent SIV(mac251) at 25 weeks postvaccination. In contrast to the two naive controls that died by 12 and 18 weeks postchallenge, all vaccinated animals remained healthy for more than 32 weeks. In addition, postchallenge cell- associated virus load was significantly lower in SIV(HyIFN)-immunized animals than in the group vaccinated with SIV(Δnef). These findings indicate that cytokine-expressing viruses can provide a novel approach for development of safe and efficacious live attenuated vaccines for AIDS.

AB - Simian immunodeficiency virus (SIV) infection of macaques is a model for human immunodeficiency virus (HIV) infection. We have previously reported the construction and characterization of an SIV vector with a deletion in the nef gene (SIV(Δnef)) and expressing gamma interferon (SIV(HyIFN)) (L. Giavedoni and T. Yilma, J. Virol. 70:2247-2251, 1996). We now show that rhesus macaques vaccinated with SIV(HyIFN) have a lower viral load than a group similarly immunized with SIV(Δnef). Viral loads remained low in the SIV(HyIFN)- vaccinated group even though SIV expressing gamma interferon could not be isolated after 6 weeks postimmunization in these animals. All immunized and two naive control macaques became infected when challenged with virulent SIV(mac251) at 25 weeks postvaccination. In contrast to the two naive controls that died by 12 and 18 weeks postchallenge, all vaccinated animals remained healthy for more than 32 weeks. In addition, postchallenge cell- associated virus load was significantly lower in SIV(HyIFN)-immunized animals than in the group vaccinated with SIV(Δnef). These findings indicate that cytokine-expressing viruses can provide a novel approach for development of safe and efficacious live attenuated vaccines for AIDS.

UR - http://www.scopus.com/inward/record.url?scp=0031023570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031023570&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 866

EP - 872

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 2

ER -